United Therapeutics Corp (UTHR)

bez780 (< 20) Submitted: 7/29/2009 10:54:21 AM : Start Price: $42.96 UTHR Score: -6.47

new drugs

LexTNZorro (74.87) Submitted: 5/4/2009 3:21:31 AM : Start Price: $33.72 UTHR Score: +10.60

http://seekingalpha.com/article/133869-fda-clinical-trial-updates-watson-pharma-united-therapeutics-auxilium-dendreon?source=feed

fanomatic (< 20) Submitted: 4/20/2009 2:44:19 PM : Start Price: $28.44 UTHR Score: -28.61

This company is limited with products..... and competition for any existing product(s) will happen soon. Its medical device company (Medicomp) is really a small marginally profitable-if at all -firm run by a youngster who was given the job AND isn't a real board certified/practicing MD.
UTHR stock owners should better prepare to SELL now before and when the stock gets to the mid 40's.

wassercom (88.24) Submitted: 2/22/2009 9:15:12 AM : Start Price: $34.59 UTHR Score: -10.24

Pipeline looks good.

nysegal (26.14) Submitted: 8/5/2008 2:24:22 AM : Start Price: $55.78 UTHR Score: -7.71

UTHR is a terrific growth stock; accellerating earnings -- 80% in 08 and 68% in 09; recently reported fantastic earnings above street estimates.

ThxUT (28.39) Submitted: 3/13/2008 12:29:05 PM : Start Price: $39.76 UTHR Score: +27.56

UT leads the market in pulmonary hypertension with rapid growth and a better product than all the competitors.

SteelBreez99 (85.72) Submitted: 12/11/2007 5:47:28 PM : Start Price: $54.00 UTHR Score: +8.71

VALUE LINES - TIMELY STOCKS IN TIMELY INDUSTRIES

qasamm (84.77) Submitted: 12/11/2007 1:45:24 PM : Start Price: $53.69 UTHR Score: +9.93

Amazing leadership- many great suprises found in each annual report (no debt, diversity of pipeline, etc.)

MFClobberMeSilly (< 20) Submitted: 11/9/2007 8:27:36 AM : Start Price: $50.01 UTHR Score: +12.67

Best biomed

kevrose31 (76.15) Submitted: 11/3/2007 5:52:34 PM : Start Price: $52.42 UTHR Score: +10.53

Wow.

jennings2 (< 20) Submitted: 5/3/2007 3:32:51 PM : Start Price: $29.60 UTHR Score: +77.44

UTHR owns the US rights to Ovarex, an immune based therapy for ovarian cancer originated from virexx corporation, in ph 3 trials. since I can't put forward REX, due to CAPS rules, UTHR is my placeholder. I think Ovarex has a very good chance of being another Provenge type cancer treatment

JasonA25 (45.59) Submitted: 3/2/2007 12:30:21 PM : Start Price: $27.56 UTHR Score: +82.74

NICE GROWTH EST, POSITIVE CASH, WILL BE A NICE STOCK FOR THE FUTURE EVEN IF THERE IS A BEAR MARKET COMING UP.

pzarker (64.44) Submitted: 11/27/2006 2:06:38 AM : Start Price: $28.98 UTHR Score: +74.88

To be honest, this is a "gut feeling" pick, i feel that their is potential here to get back up to their 52 week high level.